Press Releases
December 7, 2016
SBP to Initiate 5th Patient Cohort in its Dose Escalation Phase 1 Study of SBP-101 for Pancreatic Cancer
November 10, 2016
SBP Reports Q316 Results, Provides Clinical Progress Update
October 24, 2016
SBP to Present at the Innovation Biotech Showcase October 26
October 6, 2016
SBP Receives DSMB Approval to Start 4th Patient Cohort in SBP-101 Dose Escalation Phase 1 Study
October 3, 2016
SBP Announces Effectiveness of its Registration Statement on Form S-1
Company Uplists to OTCQB Venture Market and Secures DTC Eligibility
August 15, 2016
SBP Announces Completion of 2nd Patient Cohort, Starts Recruitment of 3rd Cohort Patients
August 11, 2016
SBP Files Form 10-Q for 2nd Quarter 2016 & Provides Business Update
June 28, 2016
Sun BioPharma, Inc. Raises $2.0 Million Through Private Placement Transaction
May 23, 2016
Sun BioPharma Completes 1st Patient Cohort & Starts Recruitment of 2nd Cohort Patients in Dose Escalation Phase 1 Study
May 16, 2016